• The Peripheral Intravenous Catheters (PIVC) Market is projected to experience significant growth, driven by the increasing demand for intravenous therapies and advancements in catheter technologies. These devices are essential for administering fluids, medications, and nutrients directly into the bloodstream, commonly employed in hospitals and outpatient settings.

• Short Peripheral IV Catheters dominate the market due to their ease of insertion, cost-effectiveness, and suitability for short-term therapies across various clinical settings. These catheters are widely used in emergency and inpatient care due to their quick access capabilities and lower complication rates.

• The Safety Peripheral IV Catheters segment is gaining traction, driven by the increasing emphasis on healthcare worker safety and the reduction of needlestick injuries. These catheters feature integrated safety mechanisms that minimize the risk of accidental needle sticks, aligning with stringent occupational safety regulations.

• Key end-users in the market include hospitals, ambulatory surgical centers, clinics, and home care settings. The growing trend of home healthcare and outpatient services has led to an increased use of peripheral IV catheters outside traditional hospital settings, catering to patients receiving long-term treatments or palliative care at home.

• The North America region holds a significant share of the market, attributed to robust healthcare infrastructure, widespread use of IV therapy in chronic disease management, and strong adoption of technologically advanced catheter solutions. The Asia-Pacific region is expected to witness the highest growth rate, driven by increasing healthcare expenditure, rising patient awareness, and expanding access to IV therapy across both urban and rural regions.

• Leading players in the market include Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Smiths Group plc., and Teleflex Incorporated, among others. These companies are focusing on product innovation, strategic partnerships, and expanding their market presence to cater to the growing demand for peripheral intravenous catheters.

• Challenges such as the risk of catheter-related complications, needlestick injuries, and the need for specialized training may impede market growth. However, ongoing research and development efforts, along with increasing adoption of safety-engineered catheters, are expected to mitigate these challenges and drive market expansion.

• In November 2023, BD (Becton, Dickinson & Company) introduced the PIVO™ Pro needle-free blood draw system, designed for use with peripheral intravenous catheters to reduce multiple needle sticks and improve patient comfort.

• In September 2024, Access Vascular, Inc. entered a strategic partnership with Capstone Health Alliance to expand access to its hydrophilic biomaterial catheter technologies across major healthcare networks.

In this report, the Peripheral Intravenous Catheters Market has been segmented by Product, Technology, End User and Geography.

Peripheral Intravenous Catheters Market, Segmentation by Product

The segmentation by Product distinguishes between Short PIVC (with sub‑types Ported PIVC and Non‑Ported PIVC) and Integrated & Closed PIVC. This differentiation reflects varying design complexity, safety features, functional versatility, and suitability for different clinical contexts. Demand for each product type is shaped by clinical requirements, regulatory preferences, and the need for safer vascular access in diverse care settings. The segmentation underscores how manufacturers and providers can tailor offering portfolios to satisfy both standard infusion needs and enhanced safety/efficiency expectations.

• Short PIVC — Ported PIVC

  Ported short PIVCs provide a simple, cost‑effective vascular access solution for short‑term infusions, fluid administration, or medication delivery. Their design supports ease of insertion, minimal training requirements, and broad applicability across inpatient and outpatient settings. As they address routine infusion needs, they constitute a substantial portion of unit demand worldwide.

• Short PIVC — Non‑Ported PIVC

  Non‑ported short PIVCs represent standard peripheral intravenous devices widely used for basic IV access such as fluids, antibiotics, or short‑term therapies. Their simplicity and low cost make them suitable for high‑volume use in hospitals and clinics, especially in settings where advanced safety features may not be mandatory. Their broad use in general infusion therapy supports stable baseline demand.

• Integrated & Closed PIVC

  Integrated and closed PIVCs incorporate advanced safety features, closed‑system designs, and may reduce risk of contamination, needlestick injuries, and catheter failure. Growing concerns around patient safety, infection control, and regulatory mandates in many regions drive preference toward such systems. This segment is gaining traction, especially in hospitals and high‑standard care settings, aligning with global shifts toward safer vascular access devices.

Peripheral Intravenous Catheters Market, Segmentation by Technology

The Technology segmentation divides the market into Conventional PIVCs and Safety PIVCs. This axis reflects the trend of technological evolution in vascular access devices from basic mechanical catheters to advanced safety‑engineered designs. The choice between conventional and safety devices significantly influences clinical outcomes, risk management, regulatory compliance, and procurement strategies. As healthcare systems increasingly prioritize patient safety and infection control, the safety PIVC segment is becoming more relevant and is expected to drive future market growth.

• Conventional PIVC

  Conventional PIVCs represent traditional peripheral catheter technology used for standard infusion therapies, short‑term IV access, fluid administration and basic medication delivery. They remain widely used due to their low cost, simplicity, and suitability for standard care scenarios. In regions or settings with constrained budgets or lower regulatory pressure, conventional PIVCs remain relevant and continue to fulfill large volumes of demand.

• Safety PIVC

  Safety‑engineered PIVCs are designed to reduce complications such as catheter‑related infections, phlebitis, accidental needlestick injuries, and catheter failure. Evidence suggests that integrated or closed PIVCs lead to lower complication rates and improved dwell time compared to conventional devices. Increasing regulatory emphasis on patient safety and infection prevention is propelling adoption of safety PIVCs, particularly in hospitals and high‑standard care settings globally. This segment is expected to record robust growth as providers favor safer vascular access solutions.

Peripheral Intravenous Catheters Market, Segmentation by End User

The market for PIVCs is segmented by End User to reflect the diverse care settings where peripheral intravenous access is required. End user segmentation helps highlight how demand varies by care environment, patient type, procedural volume and regulatory compliance requirements. Analysis across hospitals, clinics, ambulatory surgical centers, homecare settings and others provides insight into procurement patterns, usage intensity, and growth potential in each channel.

• Hospitals

  Hospitals are the primary end users for PIVCs, given high volume of inpatient admissions, surgeries, emergency care, and infusion therapies. Their need for reliable vascular access, safety compliance, and broad range of catheter types ensures strong demand for both conventional and safety‑engineered PIVCs. Hospitals also lead in adoption of integrated PIVCs due to higher regulatory scrutiny and emphasis on patient safety.

• Clinics

  Clinics — including outpatient and general physician practices — use PIVCs for basic infusion therapies, minor procedures, and short‑term IV administration. Clinics typically demand cost‑effective, easy‑to‑use catheter solutions with moderate safety requirements. Their role supports baseline market demand outside of major hospital settings, especially for routine or less complex treatments.

• Ambulatory Surgical Centers

  Ambulatory surgical centers (ASCs) use PIVCs for day‑care procedures, short surgeries, and post‑operative infusions. The growing shift toward outpatient surgical care and minimally invasive procedures supports increasing PIVC use in ASCs. These settings often balance between cost and safety, making both short PIVCs and safety PIVCs relevant depending on procedural protocols.

• Homecare Settings

  Homecare settings are increasingly using PIVCs for long‑term infusion therapies, parenteral nutrition, or chronic disease management outside hospital environments. Demand in this segment is influenced by the need for patient safety, ease of use, and reduced infection risk — factors that favor integrated and safety PIVCs. Growth in homecare adoption is driven by rising chronic disease prevalence, outpatient care trends, and preference for home‑based treatment where feasible.

• Others

  The “Others” segment includes specialized care facilities, rehabilitation centers, urgent care clinics, and non‑traditional care delivery environments. These users may require PIVCs for infusions, emergency care, or occasional IV access, contributing to incremental demand across diversified healthcare settings globally.

Peripheral Intravenous Catheters Market, Segmentation by Geography

The geographic segmentation delineates the global PIVC market into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. Geographic variation reflects differences in healthcare infrastructure, regulatory frameworks, safety standards, disease burden, and adoption of advanced catheter technologies. Regional segmentation provides insight into where growth potential is highest, where demand is stable, and where market penetration remains nascent — guiding strategic deployment, manufacturing, and distribution decisions.

North America

North America remains the leading region in the peripheral intravenous catheter market, driven by advanced healthcare infrastructure, high hospitalization rates, widespread adoption of safety‑engineered catheters, and strong regulatory emphasis on patient safety. The region commands a major share of global demand due to consistent use of PIVCs in hospitals, clinics, and ambulatory care settings. Continued investments in vascular access devices, increasing infusion therapies, and emphasis on reducing catheter‑related complications support sustained growth across conventional and integrated PIVC product lines.

Europe

Europe represents a mature market with broad penetration of peripheral IV catheters across public and private healthcare facilities, stringent safety standards, and increasing demand for advanced integrated PIVCs. Growing incidence of chronic diseases requiring long‑term infusion therapy, expanding outpatient care, and expanding homecare support are driving consistent demand. Regulatory frameworks and institutional adoption of best practices for vascular access are fueling uptake of both conventional and safety PIVCs across the region.

Asia Pacific

Asia Pacific is poised for robust growth in the PIVC market, driven by expanding healthcare infrastructure, increasing hospitalization volume, rising burden of chronic and infectious diseases, and growing need for reliable vascular access. The region’s growing focus on infection control, adoption of safety catheter technologies, and rising use of outpatient and homecare services presents substantial opportunities for both conventional and integrated PIVC segments. Rapid urbanization, rising healthcare expenditure, and increasing access in emerging economies support a strong growth trajectory.

Middle East & Africa

The Middle East & Africa region displays gradual but growing adoption of PIVCs, with demand driven by expanding healthcare access, increasing hospital capacity, and rising awareness of intravenous therapy needs. While adoption of advanced safety‑engineered PIVCs is rising slowly, conventional PIVCs remain widely used due to cost sensitivity and infrastructure variability. As healthcare infrastructure improves and regulatory standards evolve, growth in both conventional and integrated PIVC segments is anticipated.

Latin America

Latin America shows growing utilization of peripheral IV catheters across hospitals, clinics, and emerging outpatient care settings. Increasing healthcare expenditure, rising prevalence of chronic diseases, and expansion of infusion therapy services are supporting demand. The region offers growth potential for integrated and safety PIVCs as healthcare providers seek to improve patient safety and reduce catheter‑related complications while managing cost constraints.

This report provides an in depth analysis of various factors that impact the dynamics of Global Peripheral Intravenous Catheter Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Peripheral Intravenous Catheters Market reflects a moderately concentrated landscape where leading manufacturers account for nearly 55% of the market share. Companies are adopting strategies such as merger initiatives, regional partnerships, and distribution alliances to maintain competitiveness. Increasing demand for advanced vascular access solutions is driving growth and fueling long-term expansion across hospitals, clinics, and homecare facilities.

Market Structure and Concentration
The sector is led by multinational firms controlling around 60% of supply, while regional companies compete in niche segments. This structure strengthens innovation and brand recognition. Smaller players adopt cost-effective strategies, while major firms focus on merger activity to broaden product portfolios and secure consistent growth in the healthcare access devices segment.

Brand and Channel Strategies
Key players utilize strong brand positioning and multi-channel distribution, with over 45% sales generated through direct hospital partnerships. Online procurement accounts for nearly 30% of adoption, reflecting accelerated expansion. Strategic collaboration with healthcare providers and purchasing groups ensures market visibility and supports sustainable growth across emerging and developed healthcare systems.

Innovation Drivers and Technological Advancements
Ongoing technological advancements improve safety and efficiency, with needle-stick prevention and closed system designs increasing adoption by about 25%. Firms emphasize innovation in materials to enhance patient comfort and reduce infection risk. Targeted partnerships with research institutions and acquisitions expand capabilities, driving growth in advanced catheter solutions tailored to evolving clinical needs.

Regional Momentum and Expansion
North America contributes nearly 35% share due to regulatory standards and high adoption, while Europe holds close to 30%. Asia-Pacific leads with more than 40% rapid growth, supported by healthcare infrastructure development. Companies pursue expansion strategies through local collaboration and government-driven initiatives, strengthening the positive future outlook for catheter deployment worldwide.

Future Outlook
The future suggests strong advancement, with safety-engineered devices gaining over 50% preference across care settings. Companies will continue refining strategies through innovation, international merger activity, and enhanced distribution channels. Sustained growth will be supported by rising demand for infection control and patient comfort, cementing a resilient future outlook for the peripheral intravenous catheters market.

Key players in Peripheral Intravenous Catheter Market include:

• Becton Dickinson
• B. Braun Melsungen AG
• Terumo Corporation
• Smiths Medical
• Teleflex Incorporated
• Vygon SAS
• Argon Medical Devices, Inc.
• ICU Medical, Inc.
• Medical Components, Inc.
• Tangent Medical Technologies Inc.
• Vigmed AB
• C. R. Bard, Inc.
• Nipro Corporation
• BL Group of Companies
• Lars Medicare Pvt Ltd

In this report, the profile of each market player provides following information:

• Market Share Analysis
• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis